APP and Alzheimer disease: Similarly, the up-regulation of miR-206 in hippocampal tissue, cerebrospinal fluid, and plasma of APP/PSEN1 transgenic mice is also observed, and the alteration of miR-206 contributes to the pathology of AD through down-regulating BDNF (52).